CHEST 2016

February 28, 2017February 28, 2017

Bronchiectasis More Common in Severe COPD, Pneumonia as Treatment Side Effect

News

Bronchiectasis becomes more common among patients with chronic obstructive pulmonary disease (COPD) as their disease becomes more severe, and is linked to frequent exacerbations, according to a recent study. Importantly, ... Read more

November 3, 2016November 3, 2016

Case Report Suggests Diffuse Bronchiectasis May Develop from Sarcoidosis

News

Non-cystic fibrosis (CF) bronchiectasis may develop as the primary manifestation of endobronchial sarcoidosis, a disease that affects the lungs’ bronchi (the tiny sacs that make up the lungs, where respiratory ... Read more

October 19, 2016October 19, 2016

#CHEST2016 – Bayer to Present Data from Phase 3 Trial on Non-CF Bronchiectasis Therapy

News

Bayer will present data from current trials in non-cystic fibrosis (non-CF) bronchiectasis and pulmonary arterial hypertension at the American College of Chest Physicians (CHEST 2016) Oct. 22-26 in Los Angeles. “Our data reflects Bayer’s ... Read more